Insider Transactions in Q4 2023 at Revance Therapeutics, Inc. (RVNC)
Insider Transaction List (Q4 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 31
2023
|
Dustin S Sjuts President |
BUY
Grant, award, or other acquisition
|
Direct |
264
+0.17%
|
$1,848
$7.47 P/Share
|
Dec 31
2023
|
Mark J Foley CEO |
BUY
Grant, award, or other acquisition
|
Direct |
264
+0.03%
|
$1,848
$7.47 P/Share
|
Dec 31
2023
|
Tobin Schilke CFO |
BUY
Grant, award, or other acquisition
|
Direct |
434
+0.47%
|
$3,038
$7.47 P/Share
|
Dec 15
2023
|
Dustin S Sjuts President |
SELL
Payment of exercise price or tax liability
|
Direct |
4,712
-2.91%
|
$37,696
$8.08 P/Share
|